{"title":"免疫疗法的作用日益扩大。","authors":"","doi":"10.46883/ONC.2020.3410.0427","DOIUrl":null,"url":null,"abstract":"<p><p>ONCOLOGY® recently spoke with Mario Sznol, MD, professor of medicine (medical oncology) at Yale School of Medicine and Yale Cancer Center, about the rapidly expanding use of immunotherapies, the future of immuno-oncology, and the management of immune-related toxicities.</p>","PeriodicalId":520728,"journal":{"name":"Oncology (Williston Park, N.Y.)","volume":" ","pages":"427-429"},"PeriodicalIF":0.0000,"publicationDate":"2020-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"The Expanding Role of Immunotherapy.\",\"authors\":\"\",\"doi\":\"10.46883/ONC.2020.3410.0427\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>ONCOLOGY® recently spoke with Mario Sznol, MD, professor of medicine (medical oncology) at Yale School of Medicine and Yale Cancer Center, about the rapidly expanding use of immunotherapies, the future of immuno-oncology, and the management of immune-related toxicities.</p>\",\"PeriodicalId\":520728,\"journal\":{\"name\":\"Oncology (Williston Park, N.Y.)\",\"volume\":\" \",\"pages\":\"427-429\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-10-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oncology (Williston Park, N.Y.)\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.46883/ONC.2020.3410.0427\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncology (Williston Park, N.Y.)","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.46883/ONC.2020.3410.0427","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
ONCOLOGY® recently spoke with Mario Sznol, MD, professor of medicine (medical oncology) at Yale School of Medicine and Yale Cancer Center, about the rapidly expanding use of immunotherapies, the future of immuno-oncology, and the management of immune-related toxicities.